AGY Allergy Therapeutics plc

LSE · GB · Healthcare · Drug Manufacturers - Specialty & Generic · allergytherapeutics.com

4.750GBp0.00%Mkt Cap: 326.95M $P/E: —1d ago

Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally.…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited

$56.90BUSD

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB (publ)

$14.14BUSDP/E 110.6

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporated

$11.25BUSD

RDY

Dr. Reddy's Laboratories Limited

Amneal Pharmaceuticals, Inc.

$7.09BUSDP/E 41.5

HIMS

Hims & Hers Health, Inc.

$6.92BUSD

LNTH

Lantheus Holdings, Inc.

$6.54BUSDP/E 24.3

KNSA

Kiniksa Pharmaceuticals International, plc

Key Statistics

Company

Market Cap326.95M USD

Enterprise Value335.20M USD

Revenue (TTM)62.28M USD

Gross Profit31.85M USD

Net Income (TTM)-43.62M USD

Revenue/Share0.01 GBp

Last Price4.750 GBp

Fiscal Year EndJun 2025

MR QuarterDec 2025

Employees584

CountryGB

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-6.60

PEG—

EV/EBITDA-9.76

EV/Revenue5.38

P/S5.25

P/B47.50

EPS (TTM)-0.01

EPS (Forward)-0.01

52W Range

0.000039% of range12.10

52W High12.10 GBp

52W Low0.0000 GBp

Profitability

Gross Margin53.23%

Oper. Margin-31.35%

EBITDA Margin-55.16%

Profit Margin-72.91%

ROE142.35%

ROA-59.42%

Growth

Revenue Growth6.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-30.55M USD

CapEx (TTM)3.72M USD

FCF Margin-42.18%

FCF Yield-8.04%

Net Debt18.12M USD

Net Debt/EBITDA-0.53

Balance Sheet

Debt/Equity-2.13

Current Ratio1.13

Quick Ratio0.70

Book Value/Sh0.0010 GBp

Cash/Share0.0020 GBp

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 GBp

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating1.0 (Strong Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)13.00 GBp

Upside (mean)+173.7%

Target Range13.00 GBp – 13.00 GBp

# Analysts1

Ownership

Shares Out.6.33B

Float701.97M

Insiders88.78%

Institutions0.01%

Technical

SMA 505.193 (-8.5%)

SMA 2008.715 (-45.5%)

Beta0.83

S&P 52W Chg14.58%

Avg Vol (30d)402.62K

Avg Vol (10d)77.42K

Technical Indicators

RSI (14)36.7

MACD-0.2033

MACD Signal-0.2317

MACD Hist.+0.0284

BB Upper5.253 GBp

BB Middle4.868 GBp

BB Lower4.483 GBp

BB Width15.82%

ATR (14)0.4506 GBp

Vol Ratio (20d)0.04x